Literature DB >> 8014499

Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections.

R L Ashley1, L Corey, J Dalessio, P Wilson, M Remington, G Barnum, P Trethewey.   

Abstract

Antibodies to herpes simplex virus (HSV) have been demonstrated in cervicovaginal secretions but have not been analyzed for their viral protein targets, prevalence, isotype, or kinetics of development. A method was devised to collect cervical secretions from women with primary genital HSV-2. By Western blot, cervical IgG and IgA responses to HSV-2 proteins VP5, gB, and gD were detected in most patients within 2 weeks of onset and to gC/gE within 3 weeks. Cervical IgM and IgG responses to gG, VP16, and ICP35 developed later and were more variable. Cervical IgM to most proteins appeared within 6-10 days. Cervical IgA and IgG persisted for weeks, but cervical IgM waned. Western blot profiles of serum IgG and cervical IgG to individual HSV-2 proteins were similar; those of serum IgA and cervical IgA differed. These findings suggest a universal, complex immune response to HSV-2 infection in the female genital tract.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014499     DOI: 10.1093/infdis/170.1.20

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.

Authors:  L A Morrison; L Zhu; L G Thebeau
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2.

Authors:  E L Parr; M B Parr
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy.

Authors:  M Arvaja; M Lehtinen; P Koskela; M Lappalainen; J Paavonen; T Vesikari
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

4.  Sensitive method for detection of human herpesviruses 6 and 7 in saliva collected in field studies.

Authors:  D M Zerr; M L Huang; L Corey; M Erickson; H L Parker; L M Frenkel
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Molecular characterization of the cervical and systemic B-cell repertoire: Unique, yet overlapping, immune compartments of an HIV-1 resistant individual.

Authors:  Ryan G Gaudet; Felix Breden; Frank Plummer; Jody D Berry
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

6.  Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis.

Authors:  D Provenzano; J F Alderete
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.

Authors:  Francois-Xavier Mbopi-Kéou; Laurent Bélec; Julie Dalessio; Jérôme Legoff; Gérard Grésenguet; Philippe Mayaud; David W G Brown; Rhoda Ashley Morrow
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model.

Authors:  Amanda Kwant-Mitchell; Ali A Ashkar; Kenneth L Rosenthal
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

Review 9.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Collection of cervical secretions does not adversely affect Pap smears taken immediately afterward.

Authors:  A Hildesheim; M C Bratti; R P Edwards; M Schiffman; A C Rodriguez; R Herrero; M Alfaro; L A Morera; S V Ermatinger; B T Miller; P A Crowley-Nowick
Journal:  Clin Diagn Lab Immunol       Date:  1998-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.